Guardian Pharmacy Services (NYSE:GRDN) Shares Gap Down After Earnings Miss

Guardian Pharmacy Services, Inc. (NYSE:GRDN) shares gapped down prior to trading on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $20.23, but opened at $19.51. Guardian Pharmacy Services shares last traded at $21.64, with a volume of 10,025 shares trading hands.

The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.01). The firm had revenue of $321.10 million during the quarter, compared to the consensus estimate of $329.85 million.

Institutional Trading of Guardian Pharmacy Services

Several hedge funds and other institutional investors have recently made changes to their positions in GRDN. R Squared Ltd bought a new stake in Guardian Pharmacy Services in the fourth quarter worth $30,000. Investment Research & Advisory Group Inc. bought a new position in Guardian Pharmacy Services in the 4th quarter worth about $34,000. BNP Paribas Financial Markets purchased a new stake in Guardian Pharmacy Services during the 4th quarter valued at about $37,000. Compass Financial Services Inc bought a new stake in Guardian Pharmacy Services during the 4th quarter valued at about $58,000. Finally, JPMorgan Chase & Co. bought a new position in shares of Guardian Pharmacy Services in the fourth quarter worth approximately $77,000.

Guardian Pharmacy Services Trading Up 7.0 %

The company’s fifty day moving average is $20.54.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.